Susan Abushakra
Chief Tech/Sci/R&D Officer chez ALZHEON, INC.
Profil
Susan Abushakra is the founder of Bonti, Inc. founded in 2015, where she holds the title of Chief Medical Officer.
She is currently the Chief Medical Officer at Alzheon, Inc. since 2015 and a Member of the Alzheimer's Association.
Dr. Abushakra's former positions include Chief Medical Officer at Transition Therapeutics, Inc., Vice President-Clinical Development at Elan Corp., and Chief Medical Officer at Perrigo Co. Plc in 2014.
Dr. Abushakra received a doctorate degree from the American University of Beirut.
Postes actifs de Susan Abushakra
| Sociétés | Poste | Début |
|---|---|---|
| ALZHEON, INC. | Chief Tech/Sci/R&D Officer | 01/07/2015 |
Bonti, Inc.
 Bonti, Inc. Pharmaceuticals: MajorHealth Technology Bonti, Inc. develops novel treatments. It specializes in both aesthetic and therapeutic indications. The company was founded by Fauad Hasan, Mike Jarpe, Wajdie Ahmad, Jonathan Lim, David Ramsay and Susan Abushakra in 2015 and is headquartered in Newport Beach, CA. | Founder | 01/01/2015 |
Alzheimer’s Association
 Alzheimer’s Association Miscellaneous Commercial ServicesCommercial Services The Alzheimer's Association is a non-profit organization based in Chicago, IL and has subsidiaries in the United States. The non-profit company provides information and resources for Alzheimer's and other dementias. Joanne Pike has been the CEO of the company since 2021. | Corporate Officer/Principal | - |
Anciens postes connus de Susan Abushakra
| Sociétés | Poste | Fin |
|---|---|---|
| PERRIGO COMPANY PLC | Chief Tech/Sci/R&D Officer | 01/06/2014 |
| ELAN CORPORATION | Corporate Officer/Principal | - |
| TRANSITION THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | - |
Formation de Susan Abushakra
| American University of Beirut | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ELAN CORPORATION | Health Technology |
| PERRIGO COMPANY PLC | Health Technology |
| Entreprise privées | 4 |
|---|---|
Transition Therapeutics, Inc.
 Transition Therapeutics, Inc. Medical SpecialtiesHealth Technology Transition Therapeutics, Inc. develops novel therapeutics for disease indications. It operates through research and development of therapeutic agents segment. The firm's products include ELND005 for the treatment of alzheimer's disease, bipolar disorder and down syndrome. Its metabolic drug candidate is TT401 for treatment of type 2 diabetes and accompanying obesity. Transition Therapeutics was founded by Tony F. Cruz on July 6, 1998 and is headquartered in Toronto, Canada. | Health Technology |
Alzheon, Inc.
 Alzheon, Inc. BiotechnologyHealth Technology Alzheon, Inc. engages in the provision of medical development. It specializes in treatment for brain health, memory, and aging. It offers ALZ-801, an oral small molecule inhibitor of amyloid formation and neurotoxicity with potential to be a therapy for a genetically defined population of patients with or at high risk for Alzheimer's disease and other neurodegenerative disorders. The company was founded by Martin Tolar in June 2013 and is headquartered in Framingham, MA. | Health Technology |
Alzheimer’s Association
Alzheimer’s Association Miscellaneous Commercial ServicesCommercial Services The Alzheimer's Association is a non-profit organization based in Chicago, IL and has subsidiaries in the United States. The non-profit company provides information and resources for Alzheimer's and other dementias. Joanne Pike has been the CEO of the company since 2021. | Commercial Services |
Bonti, Inc.
Bonti, Inc. Pharmaceuticals: MajorHealth Technology Bonti, Inc. develops novel treatments. It specializes in both aesthetic and therapeutic indications. The company was founded by Fauad Hasan, Mike Jarpe, Wajdie Ahmad, Jonathan Lim, David Ramsay and Susan Abushakra in 2015 and is headquartered in Newport Beach, CA. | Health Technology |
